Confronting legacies of underrepresentation in clinical trials: The case for greater diversity in research
- PMID: 35032427
- DOI: 10.1016/j.neuron.2021.12.008
Confronting legacies of underrepresentation in clinical trials: The case for greater diversity in research
Abstract
Involvement of women and racial/ethnic minorities is critical to the scientific, economic, and ethical value of clinical trials. Despite legal precedents, diversity and inclusion in trials have been suboptimal. I present strategies to help investigators increase representation.
Copyright © 2021 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests The author declares no competing interests.